Phase II study of everolimus (Afinitor®) for children with recurrent or progressive ependymoma Meeting Abstract


Authors: Bowers, D.; Karajannis, M.; Gardner, S.; Su, J.; Baxter, P.; Partap, S.; Klesse, L.
Abstract Title: Phase II study of everolimus (Afinitor®) for children with recurrent or progressive ependymoma
Meeting Title: 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2020 Nov 19-21
Meeting Location: Virtual
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2020-11-01
Start Page: ii54
Language: English
ACCESSION: WOS:000590061300219
PROVIDER: wos
DOI: 10.1093/neuonc/noaa215.005
Notes: Meeting Abstract: CTNI-52 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors